Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
D000667:Ampicillin / Q000378:metabolism; D000818:Animals; D001646:Bile / Q000378:metabolism; D002509:Cephaloridine / Q000378:metabolism; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002512:Cephalothin / Q000378:metabolism; D004285:Dogs; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000378:metabolism
D002511:Cephalosporins; D000667:Ampicillin; D002509:Cephaloridine; D002512:Cephalothin